Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (47)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Afman, L.A.
Right arrow Articles by Blom, H.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Afman, L.A.
Right arrow Articles by Blom, H.J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Q J Med 2001; 94: 159-166
© 2001 Association of Physicians

Reduced vitamin B12 binding by transcobalamin II increases the risk of neural tube defects

L.A. Afman, N.M.J. Van Der Put, C.M.G. Thomas1, J.M.F. Trijbels and H.J. Blom

From the Department of Pediatrics 1 Laboratory of Endocrinology and Reproduction, University Medical Center, Nijmegen, The Netherlands

Received 6 November 2000 Periconceptional folic acid supplementation reduces the risk of neural tube defects (NTD). Homocysteine levels are elevated in mothers of NTD children, which may be due to decreased cellular vitamin B12 levels, as vitamin B12 is a cofactor for the methylation of homocysteine. Transcobalamin II (TC II) transports vitamin B12 to the tissues. To examine whether altered plasma transcobalamin levels are a risk factor for NTD, we determined the apo and holo form of TC II and haptocorrin (TCI+TCIII), vitamin B12 and homocysteine concentrations in the plasma of 46 mothers with NTD children, and in 73 female controls. Holo-tc II levels and holo-tc II percentages (holo-tc II/total tc II) in the first quartile of the control distribution were related to a three-fold (OR 2.9, 95%CI 0.9–9.2) and five-fold (OR 5.0, 95%CI 1.3–19.3) risk, respectively, for having a child with NTD, when compared with the last quartile. Homocysteine levels were significantly higher among individuals with low holo-tc II, low total vitamin B12 concentrations and low holo-tc II percentages. These low holo-tc II percentages are probably caused by reduced affinity of TC II for vitamin B12, which may be explained by genetic variation in the TC II gene. Vitamin B12 supplementation might therefore be warranted, in addition to folate, in the prevention of NTD.

Address correspondence to Dr H.J. Blom, Department of Pediatrics, University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands. e-mail: H.Blom{at}ckslkn.azn.nl


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
cfpHome page
M. Ryan-Harshman and W. Aldoori
Vitamin B12 and health
Can Fam Physician, April 1, 2008; 54(4): 536 - 541.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
H. Refsum, C. Johnston, A. B. Guttormsen, and E. Nexo
Holotranscobalamin and Total Transcobalamin in Human Plasma: Determination, Determinants, and Reference Values in Healthy Adults
Clin. Chem., January 1, 2006; 52(1): 129 - 137.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
R. Obeid, W. Munz, M. Jager, W. Schmidt, and W. Herrmann
Biochemical indexes of the B vitamins in cord serum are predicted by maternal B vitamin status
Am. J. Clinical Nutrition, July 1, 2005; 82(1): 133 - 139.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
K. M von Castel-Dunwoody, G. P. Kauwell, K. P Shelnutt, J. D Vaughn, E. R Griffin, D. R Maneval, D. W Theriaque, and L. B Bailey
Transcobalamin 776C->G polymorphism negatively affects vitamin B-12 metabolism
Am. J. Clinical Nutrition, June 1, 2005; 81(6): 1436 - 1441.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
H. Zetterberg, E. Nexo, B. Regland, L. Minthon, R. Boson, M. Palmer, L. Rymo, and K. Blennow
The Transcobalamin (TC) Codon 259 Genetic Polymorphism Influences Holo-TC Concentration in Cerebrospinal Fluid from Patients with Alzheimer Disease
Clin. Chem., July 1, 2003; 49(7): 1195 - 1198.
[Full Text] [PDF]


Home page
Hum ReprodHome page
H. Zetterberg, B. Regland, M. Palmer, L. Rymo, A. Zafiropoulos, D.A. Arvanitis, D.A. Spandidos, and K. Blennow
The transcobalamin codon 259 polymorphism influences the risk of human spontaneous abortion
Hum. Reprod., December 1, 2002; 17(12): 3033 - 3036.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
K. J.A. Lievers, L. A. Afman, L. A.J. Kluijtmans, G. H.J. Boers, P. Verhoef, M. den Heijer, F. J.M. Trijbels, and H. J. Blom
Polymorphisms in the Transcobalamin Gene: Association with Plasma Homocysteine in Healthy Individuals and Vascular Disease Patients
Clin. Chem., September 1, 2002; 48(9): 1383 - 1389.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. W. Miller, M. I. Ramos, M. G. Garrod, M. A. Flynn, and R. Green
Transcobalamin II 775G>C polymorphism and indices of vitamin B12 status in healthy older adults
Blood, June 28, 2002; 100(2): 718 - 720.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. Drazkowski, J. Sirven, and D. Blum
Symptoms of B12 deficiency can occur in women of child bearing age supplemented with folate
Neurology, May 28, 2002; 58(10): 1572 - 1573.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Ulleland, I. Eilertsen, E. V. Quadros, S. P. Rothenberg, S. N. Fedosov, E. Sundrehagen, and L. Orning
Direct Assay for Cobalamin Bound to Transcobalamin (Holo-Transcobalamin) in Serum
Clin. Chem., March 1, 2002; 48(3): 526 - 532.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.